Liberal vs. conservative vasopressor use to maintain mean arterial blood pressure during resuscitation of septic shock: An observational study

Intensive Care Medicine

Volumn 34, Issue 1, 2008, Pages 157-162

  Subramanian, Sanjay ^a,b   Yilmaz, Murat ^a,c   Rehman, Ahmer ^a   Hubmayr, Rolf D ^a   Afessa, Bekele ^a   Gajic, Ognjen ^a  

^a MAYO CLINIC   (United States)

^b The Everett Clinic   (United States)

^c AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Resuscitation; Septic shock; Vasopressor

Indexed keywords

DOPAMINE; HYPERTENSIVE FACTOR; NORADRENALIN; PHENYLEPHRINE; VASOPRESSIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; FEMALE; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MULTIPLE ORGAN FAILURE; OBSERVATIONAL STUDY; RESUSCITATION; SEPTIC SHOCK;

AGED; AGED, 80 AND OVER; BLOOD PRESSURE; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OBSERVATION; OUTCOME ASSESSMENT (HEALTH CARE); RESUSCITATION; RETROSPECTIVE STUDIES; SHOCK, SEPTIC; VASOCONSTRICTOR AGENTS;

EID: 38149108894     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-007-0862-1     Document Type: Article

References (16)

1. Antonelli M, Levy M, Andrews PJD, Hudson LD, Manthous C, Meduri UG, Moreno IP, Putensen C, Stewart T, Torres A (2007) Hemodynamic monitoring in shock and implications for management. Intensive Care Medicine 33:575-590
2. Beale RJ, Hollenberg SM, Vincent JL, Parrillo JE (2004) Vasopressor and inotropic support in septic shock: an evidence-based review. Crit Care Med 32:455-465
3. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM (2004) Surviving sepsis campaign guidelines. Crit Care Med 32:858-873
4. Kirchheim HR, Ehmke H, Hackenthal E, Lowe W, Persson P (1987) Autoregulation of renal blood flow, glomerular filtration and renin release in conscious dogs. Pflugers Arch 410:441-449
5. Tang W, Pakula JL, Weil MH, Noc M, Fukui M, Bisera J (1996) Adrenergic vasopressor agents and mechanical ventilation for the treatment of experimental septic shock. Crit Care Med 24:125-130
6. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368-1377
7. Vincent JL, de Mendonca A, Cantraine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S (1998) The use of SOFA score to assess the incidence of organ failure in intensive care units: results of a multicenter prospective study. Crit Care Med 26:1793-1800
8. Levy MM, Macias WL, Vincent JL, Russell JA, Silva E, Trzaskoma B, Williams MD (2005) Early changes in organ function predict eventual survival in severe sepsis. Crit Care Med 33:2194-2201
9. Lin SM, Huang CD, Lin HC, Liu CY, Wang CH, Kuo HP (2006) A modified goal-directed protocol improves clinical outcomes in intensive care unit patients with septic shock: a randomized controlled trial. Shock 26:551-557
10. Institute for Healthcare Improvement "Sepsis Bundle": Available online at http://www.ihi.org/IHI/Topics/CriticalCare/Sepsis. Accessed 10 September 2006. http://www.ihi.org/IHI/Topics/CriticalCare/Sepsis/
11. Varpula M, Tallgren M, Saukkonen K, Voipio-Pulkki LM, Pettila V (2005) Hemodynamic variables related to outcome in septic shock. Intensive Care Med 31:1066-1071
12. Ledoux D, Astiz ME, Carpati CM, Rackow EC (2000) Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med 28:2729-2732
13. Bourgoin A, Leone M, Delmas A, Garnier F, Albanese J, Martin C (2005) Incr easing mean arterial pressure in patients with septic shock: effects on oxygen variables and renal function. Crit Care Med 33:780-786
14. Morimatsu H, Singh K, Uchino S, Bellomo R, Hart G (2004) Early and exclusive use of Norepinephrine in septic shock. Resuscitation 62:249-254
15. Sennoun N, Montemont C, Gibot S, Lacolley P, Levy B (2007) Comparative effects of early versus delayed use of norepinephrine in resuscitated endotoxic shock. Crit Care Med 35:1-5
16. Lopez A, Lorente JA, Steingrub J, Bakker J, McLuckie A, Willatts S, Brockway M, Anzueto A, Holzapfel L, Breen D, Silverman MS, Takala J, Donaldson J, Arneson C, Grove G, Grossman S, Grover R (2004) Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 32:21-30